These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10575627)

  • 1. Solid lipid nanoparticles (SLN/Lipopearls)--a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products.
    Dingler A; Blum RP; Niehus H; Müller RH; Gohla S
    J Microencapsul; 1999; 16(6):751-67. PubMed ID: 10575627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of ergocalciferol loaded solid lipid nanoparticles.
    Patel MR; San Martin-Gonzalez MF
    J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skin.
    Jenning V; Gysler A; Schäfer-Korting M; Gohla SH
    Eur J Pharm Biopharm; 2000 May; 49(3):211-8. PubMed ID: 10799811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
    Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
    Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting.
    Chen H; Chang X; Du D; Liu W; Liu J; Weng T; Yang Y; Xu H; Yang X
    J Control Release; 2006 Jan; 110(2):296-306. PubMed ID: 16325954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heptapeptide-loaded solid lipid nanoparticles for cosmetic anti-aging applications.
    Suter F; Schmid D; Wandrey F; Zülli F
    Eur J Pharm Biopharm; 2016 Nov; 108():304-309. PubMed ID: 27343822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of SLN and NLC enriched hydrogels for transdermal delivery of nitrendipine: in vitro and in vivo characteristics.
    Bhaskar K; Krishna Mohan C; Lingam M; Jagan Mohan S; Venkateswarlu V; Madhusudan Rao Y; Bhaskar K; Anbu J; Ravichandran V
    Drug Dev Ind Pharm; 2009 Jan; 35(1):98-113. PubMed ID: 18665979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies.
    Farboud ES; Nasrollahi SA; Tabbakhi Z
    Int J Nanomedicine; 2011; 6():611-7. PubMed ID: 21674018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idebenone loaded solid lipid nanoparticles: calorimetric studies on surfactant and drug loading effects.
    Sarpietro MG; Accolla ML; Puglisi G; Castelli F; Montenegro L
    Int J Pharm; 2014 Aug; 471(1-2):69-74. PubMed ID: 24845103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the commonly used pH-stat method with back titration really quantify the enzymatic digestibility of lipid drug delivery systems? A case study on solid lipid nanoparticles (SLN).
    Heider M; Hause G; Mäder K
    Eur J Pharm Biopharm; 2016 Dec; 109():194-205. PubMed ID: 27789354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.
    Marto J; Sangalli C; Capra P; Perugini P; Ascenso A; Gonçalves L; Ribeiro H
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1792-1800. PubMed ID: 28581831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cosmetic applications for solid lipid nanoparticles (SLN).
    Wissing SA; Müller RH
    Int J Pharm; 2003 Mar; 254(1):65-8. PubMed ID: 12615411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the crystallinity of lipid nanoparticles on their occlusive properties.
    Wissing S; Müller R
    Int J Pharm; 2002 Aug; 242(1-2):377-9. PubMed ID: 12176283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
    Jansook P; Fülöp Z; Ritthidej GC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
    Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
    Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.